Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolutegravir in Pregnant HIV Mothers
NCT03249181Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Jan 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Liverpool. Started Jan 2018; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03249181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249181.